Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1985 1
1988 1
1989 1
1990 2
1995 1
1996 1
1999 2
2000 2
2001 4
2002 2
2003 7
2004 1
2005 6
2006 11
2007 10
2008 14
2009 20
2010 30
2011 37
2012 36
2013 59
2014 84
2015 72
2016 90
2017 112
2018 117
2019 100
2020 116
2021 157
2022 190
2023 173
2024 62

Text availability

Article attribute

Article type

Publication date

Search Results

1,342 results

Results by year

Filters applied: . Clear all
Page 1
Neoantigens: promising targets for cancer therapy.
Xie N, Shen G, Gao W, Huang Z, Huang C, Fu L. Xie N, et al. Signal Transduct Target Ther. 2023 Jan 6;8(1):9. doi: 10.1038/s41392-022-01270-x. Signal Transduct Target Ther. 2023. PMID: 36604431 Free PMC article. Review.
Unspliced XBP1 Counteracts β-Catenin to Inhibit Vascular Calcification.
Yang L, Dai R, Wu H, Cai Z, Xie N, Zhang X, Shen Y, Gong Z, Jia Y, Yu F, Zhao Y, Lin P, Ye C, Hu Y, Fu Y, Xu Q, Li Z, Kong W. Yang L, et al. Among authors: xie n. Circ Res. 2022 Jan 21;130(2):213-229. doi: 10.1161/CIRCRESAHA.121.319745. Epub 2021 Dec 6. Circ Res. 2022. PMID: 34870453
Targeting HECTD3-IKKα axis inhibits inflammation-related metastasis.
Li F, Liang H, You H, Xiao J, Xia H, Chen X, Huang M, Cheng Z, Yang C, Liu W, Zhang H, Zeng L, Wu Y, Ge F, Li Z, Zhou W, Wen Y, Zhou Z, Liu R, Jiang D, Xie N, Liang B, Liu Z, Kong Y, Chen C. Li F, et al. Among authors: xie n. Signal Transduct Target Ther. 2022 Aug 3;7(1):264. doi: 10.1038/s41392-022-01057-0. Signal Transduct Target Ther. 2022. PMID: 35918322 Free PMC article.
CD38 Mediates Lung Fibrosis by Promoting Alveolar Epithelial Cell Aging.
Cui H, Xie N, Banerjee S, Dey T, Liu RM, Antony VB, Sanders YY, Adams TS, Gomez JL, Thannickal VJ, Kaminski N, Liu G. Cui H, et al. Among authors: xie n. Am J Respir Crit Care Med. 2022 Aug 15;206(4):459-475. doi: 10.1164/rccm.202109-2151OC. Am J Respir Crit Care Med. 2022. PMID: 35687485
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer.
Tsujino T, Takai T, Hinohara K, Gui F, Tsutsumi T, Bai X, Miao C, Feng C, Gui B, Sztupinszki Z, Simoneau A, Xie N, Fazli L, Dong X, Azuma H, Choudhury AD, Mouw KW, Szallasi Z, Zou L, Kibel AS, Jia L. Tsujino T, et al. Among authors: xie n. Nat Commun. 2023 Jan 17;14(1):252. doi: 10.1038/s41467-023-35880-y. Nat Commun. 2023. PMID: 36650183 Free PMC article.
Clinical features of NOTCH2NLC-related neuronal intranuclear inclusion disease.
Tian Y, Zhou L, Gao J, Jiao B, Zhang S, Xiao Q, Xue J, Wang Y, Liang H, Liu Y, Ji G, Mao C, Liu C, Dong L, Zhang L, Zhang S, Yi J, Zhao G, Luo Y, Sun Q, Zhou Y, Yi F, Chen X, Zhou C, Xie N, Luo M, Yao L, Hu Y, Zhang M, Zeng Q, Fang L, Long HY, Xie Y, Weng L, Chen S, Du J, Xu Q, Feng L, Huang Q, Hou X, Wang J, Xie B, Zhou L, Long L, Guo JF, Wang J, Yan X, Jiang H, Xu H, Duan R, Tang B, Shen L. Tian Y, et al. Among authors: xie n. J Neurol Neurosurg Psychiatry. 2022 Dec;93(12):1289-1298. doi: 10.1136/jnnp-2022-329772. Epub 2022 Sep 23. J Neurol Neurosurg Psychiatry. 2022. PMID: 36150844 Free PMC article.
Targeting cytokine-like protein FAM3D lowers blood pressure in hypertension.
Shen Y, Dong Z, Fan F, Li K, Zhu S, Dai R, Huang J, Xie N, He L, Gong Z, Yang X, Tan J, Liu L, Yu F, Tang Y, You Z, Xi J, Wang Y, Kong W, Zhang Y, Fu Y. Shen Y, et al. Among authors: xie n. Cell Rep Med. 2023 Jun 20;4(6):101072. doi: 10.1016/j.xcrm.2023.101072. Epub 2023 Jun 9. Cell Rep Med. 2023. PMID: 37301198 Free PMC article.
Disrupting metformin adaptation of liver cancer cells by targeting the TOMM34/ATP5B axis.
Jin P, Jiang J, Zhou L, Huang Z, Qin S, Chen HN, Peng L, Zhang Z, Li B, Luo M, Zhang T, Ming H, Ding N, Li L, Xie N, Gao W, Zhang W, Nice EC, Wei Y, Huang C. Jin P, et al. Among authors: xie n. EMBO Mol Med. 2022 Dec 7;14(12):e16082. doi: 10.15252/emmm.202216082. Epub 2022 Nov 2. EMBO Mol Med. 2022. PMID: 36321555 Free PMC article.
1,342 results